Tekla Life Sciences Investors:HQL

    Manage Alerts

    Overview

    As of 12/7/2021. NAV as of 12/6/2021.

     Share
    Price
    NAVPremium/
    Discount
    Current$19.24$18.663.11%
    52 Wk Avg$20.61$21.46-3.88%
    52 Wk High$22.70$24.193.11%
    52 Wk Low$18.30$18.66-11.52%
    Regular Distribution TypeManaged Distribution
    Distribution Rate8.73%
    Distribution Amount$0.4200
    Distribution FrequencyQuarterly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    To seek long-term capital appreciation by investing primarily in equity and equity related securities of US and non-US companies principally engaged in the development, production or distribution of products or services related to scientific advances in healthcare, agriculture and environmental management. Under normal market conditions, the Trust will invest at least 65% of its total assets in securities of Life Sciences Companies. The Trust may also invest up to 40% of its net assets in securities subject to legal or contractual restrictions as to resale and up to 25% in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan.

    Capital Structure

    As of 12/7/2021

    Total Investment Exposure:$460.312M
    Total Common Assets:$460.312M
    Common Shares Outstanding:24,668,382
    Annual Expense Ratios

    As of 9/30/2021

      Per Common Share
    Management FeesN/A
    Other Expenses:N/A
    Baseline Expense: N/A
    Interest Expense:N/A
    Total: 1.24%
    Fund Management

    Fund Sponsor
    Hambrecht & Quist

    Portfolio Managers
    Daniel R. Omstead

    Basics
    Category: Equity-Sector Equity
    Ticker: HQL
    NAV Ticker: XHQLX
    Average Daily Volume (shares): 75,401
    Average Daily Volume (USD): $1.548M
    Inception Date: 5/8/1992
    Inception Share Price: $15.00
    Inception NAV: $13.95
    Tender Offer: No
    Term: No
    Fiscal Year End: September 30
    Third Party Links & Reports

    Distributions

    As of 12/7/2021

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 9/30/2021
    -$0.0859
    Annualized Distribution Rate on NAV:
    As of 12/7/2021
    9.00%
    Total Return on NAV (12 months):
    As of 12/7/2021
    0.32%
    Total % Portfolio Effectively Leveraged:
    As of 12/7/2021
    0.00%

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 12/8/2021

    PeriodAvg Discount
    6 Month-1.57%
    1 Year-3.88%
    3 Year-8.16%
    5 Year-6.13%
    Z-Score

    As of 12/7/2021

    PeriodZStat
    3 Month2.01
    6 Month2.31
    1 Year2.03
    Pricing History
    Date NAV Premium / Discount

    Performance

    Calendar Year Total Returns

    As of 11/30/2021
    Category: Morningstar US CEF Sector Equity

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    YTD6.70%-4.04%19.04%12.59%
    202023.80%20.12%5.15%5.71%
    201925.51%26.46%26.64%22.38%
    2018-14.41%-7.43%-12.35%-9.96%
    201725.54%19.35%18.18%12.88%
    2016-19.49%-16.30%17.45%14.67%
    20155.87%6.90%-15.98%-12.75%
    201433.63%32.09%5.16%4.65%
    201352.19%51.98%16.34%17.44%
    201237.16%27.20%12.53%11.75%
    201120.67%16.32%-1.05%0.79%
    201020.45%11.76%20.02%17.83%
    200914.78%11.24%50.36%35.04%
    2008-27.85%-23.75%  
    20077.24%16.90%  
    2006-4.92%-1.07%  
    200512.00%9.09%  
    200410.96%6.31%  
    200342.06%24.97%  
    2002-36.09%-35.74%  
    200114.01%1.02%  
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 11/30/2021
    Category: Morningstar US CEF Sector Equity

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Number of Holdings:
    As of 6/30/2021
    138
    Annual Portfolio Turnover:
    As of 9/30/2021
    62.37%
    Asset Allocation

    As of 6/30/2021 reported by Fund Sponsor

    Top Sectors

    As of 6/30/2021 reported by Fund Sponsor

    Sector%Portfolio
    Defensive (Super Sector)91.51%
    Healthcare91.51%
    Preferred Stock6.25%
    Corporate (Super Sector)6.25%
    Cash Equivalents3.04%
    Cash Equivalents (Super Sector)3.04%
    Financial Services0.15%
    Cyclical (Super Sector)0.15%
    Top Holdings

    As of 6/30/2021 reported by Fund Sponsor

    HoldingValue% Portfolio
    Moderna Inc$39.39M7.43%
    Gilead Sciences Inc$35.38M6.67%
    Amgen Inc$28.09M5.30%
    Illumina Inc$27.81M5.24%
    Vertex Pharmaceuticals Inc$23.68M4.47%
    Regeneron Pharmaceuticals Inc$23.64M4.46%
    Biogen Inc$21.22M4.00%
    Horizon Therapeutics PLC$20.49M3.86%
    Seagen Inc Ordinary Shares$15.12M2.85%
    Other Liability$-11.38M-2.15%
    Credit Quality

    As of 6/30/2021 reported by Fund Sponsor

    Country Allocation

    As of 6/30/2021 reported by Fund Sponsor

    Country% Portfolio
    United States - Equity85.44%
    China - Equity2.88%
    Switzerland - Equity2.07%
    Germany - Equity0.94%
    United Kingdom - Equity0.59%
    Canada - Equity0.50%
    Netherlands - Equity0.25%
    Israel - Equity0.14%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.

    NOTES:

    Distribution type sourced from Morningstar. In general, managed distributions may be sourced from net investment income, realized gains and return of capital. CEFConnect.com does not undertake to disclose specific information about closed-end fund distribution sources. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.

    EWB-1456789PR-Y1220W